Navigation Links
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress

approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

About GPC Biotech

GPC Biotech AG is a biopharmaceutical company discovering and developing new anticancer drugs. GPC Biotech's lead product candidate -- satraplatin -- has achieved target enrollment in a Phase 3 registrational trial as a second-line chemotherapy treatment in hormone-refractory prostate cancer. The U.S. FDA has granted fast track designation to satraplatin for this indication, and GPC Biotech has completed the rolling NDA submission process for this compound. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors. GPC Biotech AG is headquartered in Martinsried/Munich (Germany), and its wholly owned U.S. subsidiary has sites in Waltham, Massachusetts and Princeton, New Jersey. For additional information, please visit GPC Biotech's Web site at http://www.gpc-biotech.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains forward-looking statements, which express the current beliefs and expectations of the management of GPC Biotech AG and Pharmion Corporation, including statements relating to results of the SPARC trial and statements relating to the potential efficacy and safety profile of satraplatin. Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future results, performance or achievements to differ significantly from the results, performance or achievements expressed or im
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
Post Your Comments:
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
(Date:3/3/2015)...  The eleventh annual Tucson Symposium will be held ... research scientists, academics, oncologists and pathologists will gather to ... new outcomes in patient treatments that may significantly affect ... Ventana Medical Systems, Inc. (Ventana), a member of ... at the Hilton El Conquistador in Tucson, ...
(Date:3/3/2015)... and NEW YORK , March ... PTBI ), a biopharmaceutical company advancing protein biologic therapies ... present at the 27 th Annual ROTH Capital ... 2015, at The Ritz-Carlton, Laguna Niguel in Dana Point, ... Harrison Wehner , is scheduled to present a corporate ...
Breaking Medicine Technology:VWR Announces Expansion of Distribution Agreement with New England Biolabs 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference 2
... May 17, 2012 Telepharmacy is helping pharmacies ... and alleviate staffing shortages experienced by many rural ... States. Telepharmacy allows for a pharmacy technician to ... pharmacist through state-of-the-art telecommunications technology to prepare prescriptions. ...
...  Mylan Inc. (Nasdaq: MYL ) today announced that ... the U.S. Food and Drug Administration (FDA) for its Abbreviated ... and 300 mg. The company was the first to have ... to the FDA for Clopidogrel Tablets, 300 mg, and was ...
Cached Medicine Technology:Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 2Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 3Mylan Launches Generic Version of Plavix® Tablets 2
(Date:3/3/2015)... (March 3, 2015) (PRWEB) March 03, 2015 ... (FCV), an innovator in the travel industry for the ... trailblazing expansion plan. To fulfill his vision for the ... of 400 fun, exciting and well-compensated positions as travel ... a news sales center planned for the Boynton Beach, ...
(Date:3/3/2015)... March 3, 2015, My Positive Perspective host was ... was a unique one, not just because it was the ... two men who were both faced with monumental obstacles after ... the episode, Deierlein said to Collins, “I had the opportunity ... I’m very excited that you could join me on the ...
(Date:3/3/2015)... Zealand and Rockville, Maryland (PRWEB) March 03, 2015 ... Cornerstone Communications, LTD as its North American public ... was awarded the Manuka Lab contract because of ... consumer verticals. , Headquartered in Auckland, New Zealand, ... focused on providing clients effective, certified natural skin ...
(Date:3/3/2015)... PITTSBURGH, PA (PRWEB) March 03, 2015 ... people with schizophrenia to Medicare Part D prescription drug ... $150 million annually, a new University of Pittsburgh Graduate ... results are reported in the March issue of the ... finding that Medicare could have saved more than $5 ...
(Date:3/3/2015)... RI (PRWEB) March 03, 2015 ... announced the Department of Veterans Affairs has signed a ... effective March 1, 2015. , Under the contract, ... agencies such as the U.S. Military, Indian Health Services, ... and local government entities with competitive pricing for hospital ...
Breaking Medicine News(10 mins):Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Manuka Lab North America, Inc. Awards Cornerstone Communications, LTD North American Agency Contract 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2
... have been convincingly linked to coronary atherosclerosis in a massive, ... School of Medicine. The results of the study, to ... provide 13 vital new clues on the etiology of this ... doubles the number of gene regions previously known to predispose ...
... 13 new gene sites associated with the risk of ... previous studies. Several of the novel sites discovered ... Nature Genetics, do not appear to relate to known ... "We now have identifed 23 specific genetic ...
... SATURDAY, March 5 (HealthDay News) -- Creating a healthy eating ... improve the way you eat, researchers suggest. "Telling people ... known that for a long time," study author Barbel Knauper, ... said in a university news release. "But research has ...
... cancer symposium, the Society of Surgical Oncology will present the ... of Barrington Hills, IL, for her deep commitment and long-term ... cancer patients get the information they need to make wise ... Saturday, March 5, at the Society,s 64th annual meeting in ...
... , SATURDAY, March 5 (HealthDay News) -- Warm ... to take steps to prevent heat illness when exercising outdoors. ... tips from the National Athletic Trainers, Association (NATA) and the ... institute,s mission is to prevent sudden death in sport, especially ...
... therapy could significantly improve your function and recovery after ... issue of Stroke: Journal of the American Heart ... therapy to routine physical therapy after stroke improved motor ... living activities. It also lowered the strain on the ...
Cached Medicine News:Health News:New gene regions identified that predispose people to heart attacks, Stanford scientists say 2Health News:New gene regions identified that predispose people to heart attacks, Stanford scientists say 3Health News:International collaborative identifies 13 new heart-disease-associated gene sites 2Health News:Cancer surgery society presents top honor to Kimberly Duchossois 2Health News:Exercise Common Sense During Warm Weather Activities 2Health News:Stroke patients benefit from family involvement in exercise therapy 2
... GEs premier digital cardiovascular system that brings ... echocardiography, and a new dimension of comfort ... customer input, using Six Sigma practices, GE ... that delivers what customers want: Better image ...
... Radi invented the guidewire-mounted pressure sensor ... PressureWire5 Sensor is the only sensor ... temperature and flow. With significantly improved ... as your primary guidewire, as well ...
The Androscope i-stethos is the next revolution in electronic auscultation. Plus, the ability to filter out ambient sounds, so healthcare professionals even those in noisy places like the ER could ...
... the best EMR value for many medical ... Charting Plus™ relies heavily on a user-friendly ... improve documentation quality and increase productivity in ... specific to your medical specialty. Each program ...
Medicine Products: